Long-acting injectable antipsychotics Review and recent developments
Neurosciences. 2005; 10 (2): 126-131
en Inglés
| IMEMR
| ID: emr-73756
ABSTRACT
Long-acting injectable antipsychotics, also known as "depots", were developed in the late 1960s as an attempt to improve compliance and long-term management of schizophrenia. Despite their availability for over 30 years, guidelines for their use and data on patients for whom long-acting injectable antipsychotics are most indicated are sparse and vary considerably. A review of the perceived advantages and disadvantages of using long-acting injectable antipsychotics is provided in this article, as well as a review of the literature to update clinicians on the current advances of this therapeutic option to optimize compliance and long-term management of chronic schizophrenia
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Antipsicóticos
/
Esquema de Medicación
/
Resultado del Tratamiento
/
Risperidona
/
Preparaciones de Acción Retardada
/
Inyecciones Intramusculares
Límite:
Humanos
Idioma:
Inglés
Revista:
Neurosciences
Año:
2005
Similares
MEDLINE
...
LILACS
LIS